Further, in a CIA rhesus monkey model, Atrosab administration resulted in reduced acute-phase C-reactive protein (CRP) and IL-6 levels in serum, prevented body weight loss, delayed the onset of arthritic symptoms and improved the clinical arthritis score (Guenzi et al., 2013). The gene discussed is CRP; the disease is Arthritis.